Form 8-K - Current report:
SEC Accession No. 0001144204-15-035162
Filing Date
2015-06-03
Accepted
2015-06-02 20:36:23
Documents
5
Period of Report
2015-05-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v412349_8k.htm 8-K 40474
2 EXHIBIT 10.1 v412349_ex10-1.htm EX-10.1 14151
3 EXHIBIT 10.2 v412349_ex10-2.htm EX-10.2 55361
4 GRAPHIC image_001.jpg GRAPHIC 6212
5 GRAPHIC image_002.jpg GRAPHIC 12860
  Complete submission text file 0001144204-15-035162.txt   137790
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

EIN.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36439 | Film No.: 15908567
SIC: 3826 Laboratory Analytical Instruments